99 related articles for article (PubMed ID: 6301965)
1. Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers.
Lieberman HM; LaBrecque DR; Kew MC; Hadziyannis SJ; Shafritz DA
Hepatology; 1983; 3(3):285-91. PubMed ID: 6301965
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus: inactive carriers.
Sharma SK; Saini N; Chwla Y
Virol J; 2005 Sep; 2():82. PubMed ID: 16191199
[TBL] [Abstract][Full Text] [Related]
3. Frequent reactivations of anti-HBe-positive chronic hepatitis B in patients with no demonstrable HBV DNA in serum by polymerase chain reaction.
Lee HS; Yoon JH; Kim CY
Korean J Intern Med; 1995 Jul; 10(2):103-7. PubMed ID: 7495767
[TBL] [Abstract][Full Text] [Related]
4. Lifetime risk of liver-related outcomes and determinants in male inactive carriers of chronic hepatitis B.
Wu WJ; Lin CL; Liu CJ; Huang YW; Hu JT; Yu MW
J Med Virol; 2023 Oct; 95(10):e29138. PubMed ID: 37796044
[TBL] [Abstract][Full Text] [Related]
5. Effect of short-term prednisolone therapy in patients with severe chronic type B hepatitis.
Yoo JY; Kim HY; Park CK; Shim KS; Chung WK
Korean J Intern Med; 1989 Jan; 4(1):80-5. PubMed ID: 2487409
[TBL] [Abstract][Full Text] [Related]
6. Relationship between serum HBsAg level, HBV DNA level, and peripheral immune cells in patients with chronic hepatitis B virus infection.
Mukherjee R; Reddy PB; Arava J; Rao P; Mitnala S; Gupta R; Reddy D
Hepat Med; 2010; 2():157-62. PubMed ID: 24367213
[TBL] [Abstract][Full Text] [Related]
7. Infection with Hepatitis B Virus May Increase the Serum Concentrations of Osteopontin.
Liu HB; Chen QY; Wang XY; Zhang LJ; Hu LP; Harrison TJ; Wang C; Fang ZL
Intervirology; 2021; 64(3):126-134. PubMed ID: 33735879
[TBL] [Abstract][Full Text] [Related]
8. SCD1 inhibits HBV replication by regulating autophagy under high lipid conditions.
Du X; Shi X; Han M; Gao X; Wang C; Jiang C; Pu C
Virus Genes; 2023 Dec; 59(6):801-816. PubMed ID: 37644346
[TBL] [Abstract][Full Text] [Related]
9. New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology.
Zhu XD; Zhang WH; Li CL; Xu Y; Liang WJ; Tien P
World J Gastroenterol; 2004 Aug; 10(16):2327-9. PubMed ID: 15285013
[TBL] [Abstract][Full Text] [Related]
10. RVX-208, an inducer of Apolipoprotein A-I, inhibits the particle production of hepatitis B virus through activation of cGAS-STING pathway.
Shu D; Cheng L; Yuan K; Liu D; Wei H
Antivir Ther; 2023 Dec; 28(6):13596535231219639. PubMed ID: 38037795
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of hepatitis B virus among chronic hepatitis B patients from Pointe Noire, Republic of Congo.
Angounda BM; Ngouloubi GH; Dzia AB; Boumba LMA; Baha W; Moukassa D; Ahombo G; Ennaji MM; Ibara JR
Infect Agent Cancer; 2016; 11():51. PubMed ID: 27651827
[TBL] [Abstract][Full Text] [Related]
12. A Tat-conjugated Peptide Nucleic Acid Tat-PNA-DR Inhibits Hepatitis B Virus Replication In Vitro and In Vivo by Targeting LTR Direct Repeats of HBV RNA.
Zeng Z; Han S; Hong W; Lang Y; Li F; Liu Y; Li Z; Wu Y; Li W; Zhang X; Cao Z
Mol Ther Nucleic Acids; 2016 Mar; 5(3):e295. PubMed ID: 26978579
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Diagnostic Performances of the SD-Bioline
Dera A; Sanou AM; Ouattara MNG; Ilboudo AK; Lankoande DB; Ilboudo D; Napon-Zongo D; Gomgnimbou MK
Diagnostics (Basel); 2023 Oct; 13(19):. PubMed ID: 37835887
[TBL] [Abstract][Full Text] [Related]
14. Serum RNase L levels in patients with chronic hepatitis B virus infection.
Chen CL; Tseng TC; Liu CJ; Kao JH; Chen PJ; Yang WS
Hepatol Res; 2024 Mar; 54(3):244-251. PubMed ID: 37861347
[TBL] [Abstract][Full Text] [Related]
15. For long-term outcomes, is the impact of cirrhosis more important than HBsAg seroclearance?
Liu X; Wen X; Lu F
J Hepatol; 2024 Jan; 80(1):e31-e32. PubMed ID: 37302581
[No Abstract] [Full Text] [Related]
16. Reply to: "For long-term outcomes, is the impact of cirrhosis more important than HBsAg seroclearance?".
Lai JC; Wong GL; Yip TC
J Hepatol; 2024 Jan; 80(1):e32-e34. PubMed ID: 37821018
[No Abstract] [Full Text] [Related]
17. The Progress of Anti-HBV Constituents from Medicinal Plants in China.
Geng CA; Chen JJ
Nat Prod Bioprospect; 2018 Aug; 8(4):227-244. PubMed ID: 29978386
[TBL] [Abstract][Full Text] [Related]
18. HBeAg-Negative/Anti-HBe-Positive Chronic Hepatitis B: A 40-Year-Old History.
Bonino F; Colombatto P; Brunetto MR
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016312
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus (HBV) serological patterns among the HBsAg negative hospital attendees screened for immunization.
Kafeero HM; Ndagire D; Ocama P; Kato CD; Wampande E; Walusansa A; Kajumbula H; Kateete D; Sendagire H
Sci Rep; 2022 May; 12(1):7425. PubMed ID: 35523938
[TBL] [Abstract][Full Text] [Related]
20. Quantitative detection of hepatitis B virus DNA by real-time nucleic acid sequence-based amplification with molecular beacon detection.
Yates S; Penning M; Goudsmit J; Frantzen I; van de Weijer B; van Strijp D; van Gemen B
J Clin Microbiol; 2001 Oct; 39(10):3656-65. PubMed ID: 11574587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
